PMA device
Vitagel Surgical Hemostat
Stryker Corp. · Agent, Absorbable Hemostatic, Collagen Based (LMF, Class III) · First FDA decision Jan 25, 2007, newest Oct 11, 2013Surgical bleeding and hemostasis
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
5
PMA pathway
Device trials
4
Naming "Vitagel"
MAUDE reports
7
Brand "Vitagel", since 2015
PubMed studies
3
Mentioning "Vitagel"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Vitagel Surgical Hemostat
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 5 of 5 decisions filed under this name.
- VITAGEL SURGICAL HEMOSTATPMA supplement
P050044-S021 · Decided Oct 11, 2013 · 715 days after receipt · Normal 180 Day Track
Device type: Agent, absorbable hemostatic, collagen based (LMF) · General & Plastic Surgery
- VITAGEL SURGICAL HEMOSTATPMA supplement
P050044-S012 · Decided Jul 23, 2010 · 200 days after receipt · Normal 180 Day Track No User Fee
Device type: Agent, absorbable hemostatic, collagen based (LMF) · General & Plastic Surgery
- VITAGEL SURGICAL HEMOSTATPMA supplement
P050044-S003 · Decided Dec 17, 2007 · 41 days after receipt · Normal 180 Day Track No User Fee
Device type: Agent, absorbable hemostatic, collagen based (LMF) · General & Plastic Surgery
2 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Vitagel", any status and sponsor, newest update first.
The University of Texas Health Science Center, HoustonAcademic, hospital or other
NCT01230931 · 26 participants · Start Oct 2010 · Primary completion Apr 2012
Device: Vitagel · For: Fracture Fixation; Intra-Articular Fractures; Acetabulum
Sites: Houston, Texas
- Vitagel Revision Total Knee ArthroplastyTerminated
The Cleveland ClinicAcademic, hospital or other
NCT01923805 · 8 participants · Start Apr 2013 · Primary completion Mar 2014
Device: Vitagel · For: Failed Total Knee Arthroplasty
Sites: Cleveland, Ohio
- A Prospective Study to Evaluate the Effectiveness of a Haemostatic Agent in Primary Unilateral Total Hip ArthroplastyPivotal-lookingCompleted
The Cleveland ClinicAcademic, hospital or other
NCT01285024 · 109 participants · Start Dec 2010 · Primary completion Oct 2014
Device: Vitagel · For: Arthritis
Sites: Cleveland, Ohio
1 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Vitagel", and for the whole product code for context.
This brand
7 reports: 5 malfunction, 2 injury, 0 death
Whole product code LMF
1,445 reports: 207 malfunction, 1,171 injury, 61 death
Newest reports for this brand
- VITAGEL RT3 4.5MLInjury
STRYKER ORTHOBIOLOGICS-MALVERN
0002530131-2017-00001 · Received Jan 11, 2017 · Event dated Nov 21, 2016
Device type: Agent, Absorbable Hemostatic, Collagen Based (LMF)
Device problem as coded: Patient-Device Incompatibility; Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Peritonitis
MW5064182 · Received Aug 17, 2016 · Event dated Oct 30, 2008 · 3 other devices named on this report
Device type: Filler, Recombinant Human Bone Morphogenetic Protein, Collagen Scaffold With Metal Prosthesis, Osteoinduction (NEK)
Device problem as coded: Device Operates Differently Than Expected
Patient problem as coded: Pain; Inadequate Pain Relief; Numbness; Disc Impingement
- VITAGEL RT3 2.0MLMalfunction
STRYKER ORTHOBIOLOGICS-MALVERN
0002530131-2015-00002 · Received Feb 27, 2015 · Event dated Jan 26, 2015
Device type: Agent, Absorbable Hemostatic, Collagen Based (LMF)
Device problem as coded: Application Interface Becomes Non-Functional Or Program Exits Abnormally
Patient problem as coded: No Information
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Orthovita, Inc., dBA Stryker Orthobiologics.
Z-1353-2015 · Started Feb 26, 2015 · Posted by FDA Mar 30, 2015
Reason given: Several shipments of Vitagel product (a surgical hemostat) required to be stored at 2 -8 degrees Celsius (C) were not delivered to customers within the validated delivery time.
Cause as FDA categorized it: Storage · Device type: Implant, Dermal, For Aesthetic Use (LMH)
Z-0431-2013 · Started Jul 26, 2012 · Posted by FDA Nov 22, 2012
Reason given: When preparing plasma using VitaPrep, it was reported that a small amount of blood collected in the bottom of the centrifuge cup following the centrifugation step. Firm has since discovered that if blood is present in the Luer connection of the VitaPrep following the blood draw step, this blood could be displaced to...
Cause as FDA categorized it: Device Design · Device type: Agent, Absorbable Hemostatic, Collagen Based (LMF)
Published research
The most relevant PubMed records for "Vitagel"[tiab]. The summary above synthesizes these.
- Use of fibrin sealants in cardiovascular surgery: a systematic review.
Rousou JA · J Card Surg · 2013Comparative Study, Systematic Review
- The use of tissue sealants to deliver antibiotics to an orthopaedic surgical site with a titanium implant.
Cashman JD, Jackson JK, Mugabe C, et al. · J Orthop Sci · 2013
- Cancer-specific gene silencing through therapeutic siRNA delivery with B vitamin-based nanoassembled low-molecular-weight hydrogelators.
Patil SP, Kim SH, Jadhav JR, et al. · Bioconjug Chem · 2014Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code LMF.
- SURGIFOAM® Absorbable Gelatin SpongeFerrosan Meidcal Devices A/S · PMA 2026
- Floseal Hemostatic MatrixBaxter Healthcare Corp · PMA 2015
- SURGIFLO Hemostatic Matrix Kit with ThrombinFerrosan Meidcal Devices A/S · PMA 2025
- Helistat Absorbable Collagen Hemostatic Sponge/OraFOAM Absorbable Collagen Hemostatic SpongeIntegra LifeSciences Corporation · PMA 2019
- Instat Collagen Absorbable HemostatETHICON, Inc. · PMA 2007
- Avitene Flowable Collagen HemostatDavol Inc., Sub. C. R. Bard, Inc. · PMA 2025
- Collastat Absorbable Collagen Hemostatic AgentsIntegra LifeSciences Corporation · PMA 2009
- Floseal (R) Matrix Hemostatic Sealant and Proceed (Tm) Hemostatic SealantBaxter Healthcare Corp · PMA 2001
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.